Skip to main navigation
Aprea TherapeuticsAprea Therapeutics

    home

  • Home
  • about

  • our company
  • Our Science

  • our pipeline
  • Pipeline

  • our science
  • Contact

  • our clinical trials
  • IR Nav

  • investors & media
    • Overview
    • News & Events
    • Stock Information
    • Governance
    • Financials
    • Investor Resources

SEC Filing

SEC Filing Details

Document Details

Form
8-K
Filing Date
May 15, 2023
Document Date
May 15, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - EX-101.DEF
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

USA

3805 Old Easton Road
Doylestown, PA 18902
 

CONTACT

info@aprea.com

© 2023 Aprea Therapeutics.

    home

  • Home
  • about

  • our company
  • Our Science

  • our pipeline
  • Pipeline

  • our science
  • Contact

  • our clinical trials
  • IR Nav

  • investors & media
    • Overview
    • News & Events
    • Stock Information
    • Governance
    • Financials
    • Investor Resources